Skip to main content

Closed

HUMA: Humacyte, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-5649.2%

ROIC-117.7%

Financially safe

Stretched

Debt / equity5.67×

Interest coverage-10.8×

Current ratio3.93×

Humacyte, Inc.

HUMANASDAQ Global Select·USD·Closed

Humacyte, Inc.

HUMANASDAQ·USD·Closed

$0.65

−2.71%

$0.65

−$0.02 (2.71%)

52W Range

5thpctl

Volume

0.16×avg

Mkt Cap

109.77MUSD

P/E

-1.1TTM

Div Yield

–ann

52W Range

5thpctl

Volume

0.16×avg

Market Cap

109.77MUSD

P/E Ratio

-1.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings